Clinical Trial Update: Circulating Tumour DNA guidEd Therapy for Stage IIB/C mElanoma After surgiCal resecTION [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating circulating tumor DNA-guided therapy for stage IIB/C melanoma after surgical resection has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Melanoma (Skin), Melanoma, Stage II | Phase 2, Phase 3 | Status: TERMINATED